194 related articles for article (PubMed ID: 24304691)
1. Effects of aurothiomalate treatment on canine osteosarcoma in a murine xenograft model.
Scharf VF; Farese JP; Siemann DW; Abbott JR; Kiupel M; Salute ME; Milner RJ
Anticancer Drugs; 2014 Mar; 25(3):332-9. PubMed ID: 24304691
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic activity of honokiol in osteosarcoma.
Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor therapy inhibits lung metastasis in an osteosarcoma cell line.
Kato H; Wakabayashi H; Naito Y; Kato S; Nakagawa T; Matsumine A; Sudo A
Oncology; 2015; 88(3):139-46. PubMed ID: 25402182
[TBL] [Abstract][Full Text] [Related]
4. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo.
Hingorani P; Zhang W; Gorlick R; Kolb EA
Clin Cancer Res; 2009 May; 15(10):3416-22. PubMed ID: 19447875
[TBL] [Abstract][Full Text] [Related]
6. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
7. Apigenin induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo.
Lin CC; Chuang YJ; Yu CC; Yang JS; Lu CC; Chiang JH; Lin JP; Tang NY; Huang AC; Chung JG
J Agric Food Chem; 2012 Nov; 60(45):11395-402. PubMed ID: 23066961
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
10. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD
Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982
[TBL] [Abstract][Full Text] [Related]
11. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.
Goupil RC; Bushey JJ; Peters-Kennedy J; Wakshlag JJ
Vet Pathol; 2012 Sep; 49(5):802-10. PubMed ID: 22287649
[TBL] [Abstract][Full Text] [Related]
13. NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate.
Gobin B; Battaglia S; Lanel R; Chesneau J; Amiaud J; Rédini F; Ory B; Heymann D
Cancer Lett; 2014 Mar; 344(2):291-8. PubMed ID: 24333720
[TBL] [Abstract][Full Text] [Related]
14. The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines.
McCleese JK; Bear MD; Fossey SL; Mihalek RM; Foley KP; Ying W; Barsoum J; London CA
Int J Cancer; 2009 Dec; 125(12):2792-801. PubMed ID: 19544563
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells.
Fahey CE; Milner RJ; Kow K; Bacon NJ; Salute ME
Anticancer Drugs; 2013 Jun; 24(5):519-26. PubMed ID: 23466652
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway.
Hou CH; Lin FL; Tong KB; Hou SM; Liu JF
Biochem Pharmacol; 2014 Jun; 89(4):453-63. PubMed ID: 24685520
[TBL] [Abstract][Full Text] [Related]
17. A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents In vivo.
Comstock KE; Hall CL; Daignault S; Mandlebaum SA; Yu C; Keller ET
In Vivo; 2009; 23(5):661-8. PubMed ID: 19779098
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of 22-oxa-calcitriol and all- trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo.
Barroga EF; Kadosawa T; Okumura M; Fujinaga T
Res Vet Sci; 2000 Feb; 68(1):79-87. PubMed ID: 10684763
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]